Trinchieri G, Pflanz S and Kastelein RA: The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses. Immunity. 19:641–644. 2003. View Article : Google Scholar

Vignali DA and Kuchroo VK: IL-12 family cytokines: Immunological playmakers. Nat Immunol. 13:722–728. 2012. View Article : Google Scholar :

Sun L, He C, Nair L, Yeung J and Egwuagu CE: Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine. 75:249–255. 2015. View Article : Google Scholar :

Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH and Egwuagu CE: Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 20:633–641. 2014. View Article : Google Scholar :

Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova J, Cooper AM and Cua DJ: IL-12 and IL-23 cytokines: From discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med. 21:719–729. 2015. View Article : Google Scholar

De S and Barnes BJ: B cell transcription factors: Potential new therapeutic targets for SLE. Clin Immunol. 152:140–151. 2014. View Article : Google Scholar

Davidson A and Aranow C: Pathogenesis and treatment of systemic lupus erythematosus nephritis. Curr Opin Rheumatol. 18:468–475. 2006.

Isenberg D and Rahman A: Systemic lupus erythematosus-2005 annus mirabillis. Nat Clin Pract Rheumatol. 2:145–152. 2006. View Article : Google Scholar

Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR and Mackay F: BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 204:1959–1971. 2007. View Article : Google Scholar :

Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzová D, Sanchez-Guerrero J, Schwarting A, Merrill JT, Chatham WW, et al: A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 63:3918–3930. 2011. View Article : Google Scholar :

Furukawa F: Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus. 6:193–202. 1997. View Article : Google Scholar

Cohen PL and Eisenberg RA: Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 9:243–269. 1991. View Article : Google Scholar

Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G, Chen G, Hou C, Ma N, Shen B, et al: A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in lupus-like mice. Eur J Immunol. 46:1343–1350. 2016. View Article : Google Scholar

Vincent FB, Morand EF, Schneider P and Mackay F: The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol. 10:365–373. 2014. View Article : Google Scholar

Ma N, Xing C, Xiao H, He Y, Han G, Chen G, Hou C, Marrero B, Wang Y, Zhang S, et al: BAFF suppresses IL-15 expression in B cells. J Immunol. 192:4192–4201. 2014. View Article : Google Scholar

Cervenak L, Magyar A, Boja R and László G: Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells. Immunol Lett. 78:89–96. 2001. View Article : Google Scholar

Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G, Chen G, Hou C, Zhang L, Ma N, et al: Pre-existing CD19-independent GL7(−) Breg cells are expanded during inflammation and in mice with lupus-like disease. Mol Immunol. 71:54–63. 2016. View Article : Google Scholar

Vincent FB, Morand EF and Mackay F: BAFF and innate immunity: New therapeutic targets for systemic lupus erythematosus. Immunol Cell Biol. 90:293–303. 2012. View Article : Google Scholar

Ma N, Liu X, Xing C, Wang X, Wei Y, Han G, Chen G, Hou C, Shen B, Li Y, et al: Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells. Clin Immunol. 160:142–154. 2015. View Article : Google Scholar

Vlahakos D, Foster MH, Ucci AA, Barrett KJ, Datta SK and Madaio MP: Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol. 2:1345–1354. 1992.

Avey MT, Fenwick N and Griffin G: The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs. J Am Assoc Lab Anim Sci. 54:153–162. 2015.

Xu R, Wang R, Han G, Wang J, Chen G, Wang L, Li X, Guo R, Shen B and Li Y: Complement C5a regulates IL-17 by affecting the crosstalk between DC and gammadelta T cells in CLP-induced sepsis. Eur J Immunol. 40:1079–1088. 2010. View Article : Google Scholar

Zheng M, Xing C, Xiao H, Ma N, Wang X, Han G, Chen G, Hou C, Shen B, Li Y and Wang R: Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis. Immunol Invest. 43:705–716. 2014. View Article : Google Scholar

Xing C, Ma N, Xiao H, Wang X, Zheng M, Han G, Chen G, Hou C, Shen B, Li Y and Wang R: Critical role for thymic CD19⁺CD5⁺CD1d^hiIL-10⁺ regulatory B cells in immune homeostasis. J Leukoc Biol. 97:547–556. 2015. View Article : Google Scholar

Raij L, Azar S and Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26:137–143. 1984. View Article : Google Scholar

Navarra SV, Guzmán RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, León MG, et al: Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: A randomised, placebo-controlled, phase 3 trial. Lancet. 377:721–731. 2011. View Article : Google Scholar

Martin JC, Baeten DL and Josien R: Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol. 154:1–12. 2014. View Article : Google Scholar

Murphy G, Lisnevskaia L and Isenberg D: Systemic lupus erythematosus and other autoimmune rheumatic diseases: Challenges to treatment. Lancet. 382:809–818. 2013. View Article : Google Scholar

Wang X, Liu X, Zhang Y, Wang Z, Zhu G, Han G, Chen G, Hou C, Wang T, Ma N, et al: Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice. Clin Exp Immunol. 186:144–156. 2016. View Article : Google Scholar :

Coquery CM, Wade NS, Loo WM, Kinchen JM, Cox KM, Jiang C, Tung KS and Erickson LD: Neutrophils contribute to excess serum BAFF levels and promote CD4⁺ T cell and B cell responses in lupus-prone mice. PLoS One. 9:e1022842014. View Article : Google Scholar :

Baker KP, Edwards BM, Main SH, Choi GH, Wager RE, Halpern WG, Lappin PB, Riccobene T, Abramian D, Sekut L, et al: Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48:3253–3265. 2003. View Article : Google Scholar

Benson MJ, Dillon SR, Castigli E, Geha RS, Xu S, Lam KP and Noelle RJ: Cutting edge: The dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol. 180:3655–3659. 2008. View Article : Google Scholar

Scholz JL, Crowley JE, Tomayko MM, Steinel N, O'Neill PJ, Quinn WJ III, Goenka R, Miller JP, Cho YH, Long V, et al: BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci USA. 105:15517–15522. 2008. View Article : Google Scholar :

Umiker BR, McDonald G, Larbi A, Medina CO, Hobeika E, Reth M and Imanishi-Kari T: Production of IgG autoantibody requires expression of activation-induced deaminase in early-developing B cells in a mouse model of SLE. Eur J Immunol. 44:3093–3108. 2014. View Article : Google Scholar :